by admin_prosemble | 24th January 2025 | News, Research
Prosemble proudly announces that its initial angel investor funding round has been oversubscribed. This strong support underscores confidence in our mission to transform precision therapies.
by admin_prosemble | 13th January 2025 | News, Research
Prosemble begins Immunogenicity/Tox Studies, including Toxicity Study in NCG immunodeficient mice, in collaboration with TransCure BioServices. Exciting progress ahead! transcurebioservices.com
by admin_prosemble | 15th December 2024 | Uncategorized
Prosemble are super excited to join the AI in Health Accelerator Programme! Over the next few months, we’ll be working closely with leading experts to take our life sciences innovation to new heights. We’re deeply grateful to join a community committed to turning...
by admin_prosemble | 11th December 2024 | News, Research
The cytoskeleton is essential for cell organisation and movement, with actin filaments in eukaryotes and actin-like proteins in bacteria playing key roles. This study identifies a novel bacterial actin family in the Verrucomicrobiota phylum, forming unique...
by admin_prosemble | 11th December 2024 | Scientific Publications
A family of bacterial actin homologues forms a 3-stranded tubular structure Abstract The cytoskeleton plays a critical role in the organization and movement of cells. In Eukaryotes, actin filaments polymerize into a highly conserved double-stranded linear filamentous...
